Please use this identifier to cite or link to this item:
|Title:||Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera|
|Keywords:||Medicine;Pharmacology, Toxicology and Pharmaceutics|
|Citation:||PLoS Neglected Tropical Diseases. Vol.8, No.9 (2014)|
|Abstract:||© 2014 Pongkorpsakol et al. Cyclic AMP-activated intestinal Cl−secretion plays an important role in pathogenesis of cholera. This study aimed to investigate the effect of diclofenac on cAMP-activated Cl−secretion, its underlying mechanisms, and possible application in the treatment of cholera. Diclofenac inhibited cAMP-activated Cl−secretion in human intestinal epithelial (T84) cells with IC50of ∼20 µM. The effect required no cytochrome P450 enzyme-mediated metabolic activation. Interestingly, exposures of T84 cell monolayers to diclofenac, either in apical or basolateral solutions, produced similar degree of inhibitions. Analyses of the apical Cl−current showed that diclofenac reversibly inhibited CFTR Cl−channel activity (IC50∼10 µM) via mechanisms not involving either changes in intracellular cAMP levels or CFTR channel inactivation by AMP-activated protein kinase and protein phosphatase. Of interest, diclofenac had no effect on Na+-K+ATPases and Na+-K+-Cl−cotransporters, but inhibited cAMP-activated basolateral K+channels with IC50of ∼3 µM. In addition, diclofenac suppressed Ca2+-activated Cl−channels, inwardly rectifying Cl−channels, and Ca2+-activated basolateral K+channels. Furthermore, diclofenac (up to 200 µM; 24 h of treatment) had no effect on cell viability and barrier function in T84 cells. Importantly, cholera toxin (CT)-induced Cl−secretion across T84 cell monolayers was effectively suppressed by diclofenac. Intraperitoneal administration of diclofenac (30 mg/kg) reduced both CT and Vibrio cholerae-induced intestinal fluid secretion by ∼70% without affecting intestinal fluid absorption in mice. Collectively, our results indicate that diclofenac inhibits both cAMP-activated and Ca2+-activated Cl−secretion by inhibiting both apical Cl−channels and basolateral K+channels in intestinal epithelial cells. Diclofenac may be useful in the treatment of cholera and other types of secretory diarrheas resulting from intestinal hypersecretion of Cl−.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.